<DOC>
	<DOCNO>NCT00519519</DOCNO>
	<brief_summary>Bleeding peptic ulcer one major cause morbidity mortality hospital emergency admissions.The initial treatment endoscopic therapy follow intravenous omeprazole . However optimal dosage omeprazole know . We conduct study find optimal dosage clinical scenario .</brief_summary>
	<brief_title>Optimal Dose Omeprazole After Endoscopic Treatment Bleeding Peptic Ulcers</brief_title>
	<detailed_description>Introduction Peptic ulcer bleeding ( PUB ) common life threaten condition . Intravenous infusion high dose omeprazole ( 80mg bolus follow 8 mg/hr 72 hour ie 652 mg/72 hr ) endoscopic therapy result great reduction re-bleeding placebo . Thus regime become departmental protocol . However , evidence high dose regular dose omeprazole ( 40mg day follow saline infusion ie 120mg/72 hr ) would equally effective . We calculate high dose regimen S $ 500 expensive . The aim study determine equivalence regime prevent re-bleeding rate ( primary end-point ) , surgery mortality PUB patient . Study design This single institution prospective randomize double-blind study . All patient PUB ( Forrest classification I , IIa IIb : spurt ooze bleeding , visible vessel clot ) endoscopic treatment ( adrenaline injection and/or heater probe ) . After successful endoscopic hemostasis , patient randomize receive high regular dose omeprazole infusion . After 72 hour , group patient give oral omeprazole 40mg daily 4 week . All patient evaluate clinic end 4 week . The primary end-point rebleeding . Other secondary endpoint measure surgery , duration hospital stay death .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>1 . Above 21 year old 2 . OGD do within 48 hrs admission 3 . No recent upper GIT surgery past one month 4 . Forrest Type I , IIa &amp; IIb ulcer ( Type Ia : Spurting , Ib : Oozing , IIa : Visible vessel , IIb : Clot ) 5 . Nonmalignant ulcer 6 . Informed consent take 1 . Impaired hepatic function 2 . Pregnancy 3 . Lactation 4 . Concomitant medication ( warfarin , diazepam , phenytoin , chlarithromycin , cimetidine digoxin ) 5 . Underlying malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Rebleeding endoscopic therapy</keyword>
</DOC>